梅尼埃病人工耳蜗植入的系统综述与荟萃分析
该系统综述与荟萃分析纳入37项研究、216例梅尼埃病患者,评估人工耳蜗植入(伴或不伴迷路切除)后的言语识别、纯音测听、眩晕、耳鸣及生活质量结局。结果显示植入后听力与言语识别显著改善,耳鸣明显减轻,伴或不伴迷路切除均为可行治疗选择,术后言语感知与非梅尼埃病植入者相似。
要点
- 梅尼埃病患者人工耳蜗植入后言语识别与听力学指标显著改善。
- 耳鸣残疾量表评分显著下降,提示耳鸣得到抑制。
- 伴或不伴同期迷路切除均可行,眩晕控制良好。
核心结论
- 人工耳蜗植入伴或不伴同期迷路切除是梅尼埃病的可行治疗选择,可获得较高耳鸣抑制率与眩晕控制。
- 梅尼埃病患者植入术后言语感知结局与非梅尼埃病植入受者相似。
研究设计与样本
- 系统综述与荟萃分析,检索Medline与Embase相关文献。
- 共纳入37项研究、216例接受人工耳蜗植入的梅尼埃病患者。
- 植入时平均年龄61.4岁(范围27-85岁),平均随访1.7年(范围0-9年)。
- 44例(20.4%)患者接受迷路切除。
主要发现
- 噪声下听力测试6个月平均差值改善44.7(95%CI [8.8, 80.6]),12个月改善60.1(95%CI [35.3, 85.0])。
- Freiburger单音节测试平均差值改善46.2(95%CI [30.0, 62.4])。
- 辅音-核-辅音测试平均差值改善19.3(95%CI [8.1, 30.4])。
- 耳鸣残疾量表平均差值降低48.1(95%CI [1.0, 95.2])。
临床怎么用
- 对伴重度听力损失的梅尼埃病患者,可考虑人工耳蜗植入,必要时同期行迷路切除。
- 术前 counseling 可参考术后言语感知与非梅尼埃病植入者相似的证据。
局限性
- 纳入研究随访时间差异较大(0-9年),平均随访仅1.7年。
- 部分研究样本量有限,迷路切除亚组仅44例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Meniere's disease (MD) is a debilitating condition characterized by hearing loss, vertigo, and tinnitus. The objective of this study was to systematically investigate outcomes in MD after cochlear implantation (CoI), with and without labyrinthectomy. STUDY DESIGN: Systematic review and meta-analysis. METHODS: A systematic review of articles in Medline and Embase was performed to identify all studies of patients with MD who underwent CoI. This analysis evaluates outcomes of speech recognition, pure tone audiometry, vertigo, tinnitus, and quality of life. RESULTS: Of 321 studies identified, 37 were included, involving 216 patients. Mean age at implantation was 61.4 years (range 27-85 years) with average length of follow-up at 1.7 years (range 0-9 years). Forty-four (20.4%) patients underwent labyrinthectomy. Meta-analysis demonstrated significant improvements in audiometric outcomes following CoI. There was a statistically significant improvement in Hearing in Noise Test performance, with a mean difference improvement of 44.7 (95% confidence interval [CI] [8.8, 80.6]) at 6 months and 60.1 (95% CI [35.3, 85.0]) at 12 months. The Freiburger Monosyllabic Test (FMT) and Consonant-Nucleus-Consonant (CNC) also improved significantly, with mean difference improvements of 46.2 (95% CI [30.0, 62.4]) for FMT and 19.3 (95% CI [8.1, 30.4]) for CNC. There was a statistically significant decrease in tinnitus, as measured by a mean difference reduction of 48.1 (95% CI [1.0, 95.2]) in the Tinnitus Handicap Index. CONCLUSIONS: CoI with and without simultaneous labyrinthectomy is a viable treatment option for patients with MD, yielding high rates of tinnitus suppression and vertigo control. Post-CoI MD patients demonstrate similar postoperative speech perception outcomes to non-MD implant recipients. Laryngoscope, 131:1845-1854, 2021.
引用
- Villavisanis DF, Mavrommatis MA, Berson ER, et al. Cochlear Implantation in Meniere's Disease: A Systematic Review and Meta-Analysis. Laryngoscope. 2021. PMID: 33464598. doi:10.1002/lary.29393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。